title: Inhibition of CK2 binding to BMPRIa induces C2C12 differentiation into osteoblasts and adipocytes.
abstract: BMP2 is a growth factor that regulates the cell fate of mesenchymal stem cells into osteoblast and adipocytes. However, the detailed signaling pathways and mechanism are unknown. We previously reported a new interaction of Casein kinase II (CK2) with the BMP receptor type-Ia (BMPRIa) and demonstrated using mimetic peptides CK2.1, CK2.2 and CK2.3 that the release of CK2 from BMPRIa activates Smad signaling and osteogenesis. Previously, we showed that mutation of these CK2 sites on BMPRIa (MCK2.1 (476S-A), MCK2.2 (324S-A) and MCK2.3 (214S-A)) induced osteogenesis. However, one mutant MCK2.1 induced osteogenesis similar to overexpression of wild type BMPRIa, suggesting that the effect of this mutant on mineralization was due to overexpression. In this paper we investigated the signaling pathways involved in the CK2-BMPRIa mediated osteogenesis and identified a new signaling pathway activating adipogenesis dependent on the BMPRIa and CK2 association. Further the mechanism for adipogenesis and osteogenesis is specific to the CK2 interaction site on BMPRIa. In detail our data show that overexpression of MCK2.2 induced osteogenesis was dependent on Caveolin-1 (Cav1) and the activation of the Smad and mTor pathways, while overexpression of MCK2.3 induced osteogenesis was independent of Caveolin-1 without activation of Smad pathway. However, MCK2.3 induced osteogenesis via the MEK pathway. The adipogenesis induced by the overexpression of MCK2.2 in C2C12 cells was dependent on the p38 and ERK pathways as well as Caveolin-1. These data suggest that signaling through BMPRIa used two different signaling pathways to induce osteogenesis dependent on CK2. Additionally the data supports a signaling pathway initiated in caveolae and one outside of caveolae to induce mineralization. Moreover, they reveal the signaling pathway of BMPRIa mediated adipogenesis.
authors: Department of Biological Sciences, University of Delaware, Newark, DE, 19716, USA.
authors: Oleksandra
authors: O
authors: Moseychuk
authors: Hemanth
authors: H
authors: Akkiraju
authors: Joyita
authors: J
authors: Dutta
authors: Alex
authors: A
authors: D'Angelo
authors: Beth
authors: B
authors: Bragdon
authors: Randall L
authors: RL
authors: Duncan
authors: Anja
authors: A
authors: Nohe
references: Bone. 2011 Nov;49(5):944-54
references: 21763800
references: Oncogene. 1993 Oct;8(10):2879-87
references: 8397373
references: Growth Factors. 2004 Dec;22(4):233-41
references: 15621726
references: FEBS Lett. 2002 Jan 2;510(1-2):99-104
references: 11755539
references: Cell Metab. 2007 Jul;6(1):38-54
references: 17618855
references: Mol Cancer Res. 2005 Dec;3(12):679-84
references: 16380505
references: J Biol Chem. 2000 Jun 9;275(23):17647-52
references: 10748100
references: J Cell Biochem. 2008 Aug 1;104(5):1853-64
references: 18384126
references: Biochim Biophys Acta. 1997 Oct 24;1333(2):F105-50
references: 9395284
references: Biochem Biophys Res Commun. 2000 Feb 24;268(3):757-62
references: 10679278
references: J Neurochem. 2009 May;109(3):733-43
references: 19222702
references: Mol Cell. 1999 Oct;4(4):597-609
references: 10549291
references: J Cell Sci. 2004 Nov 15;117(Pt 24):5855-63
references: 15522893
references: Cell Signal. 2011 Apr;23(4):609-20
references: 20959140
references: Eur J Biochem. 2000 Dec;267(24):6954-67
references: 11106403
references: Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):523-31
references: 19896888
references: Nature. 2008 Aug 21;454(7207):961-7
references: 18719582
references: Biophys J. 2009 Sep 2;97(5):1428-35
references: 19720031
references: Mol Biol Cell. 2000 Mar;11(3):1023-35
references: 10712517
references: Mol Cell Biol. 2006 Oct;26(20):7791-805
references: 16923969
references: J Bone Miner Res. 2002 Oct;17(10):1785-94
references: 12369782
references: Mol Biol Cell. 2003 Feb;14(2):545-55
references: 12589053
references: Biochim Biophys Acta. 2008 Jan;1784(1):33-47
references: 17931986
references: Sci STKE. 2007 Dec 18;2007(417):pl7
references: 18089858
references: Biophys J. 2010 Aug 4;99(3):897-904
references: 20682268
references: J Biol Chem. 2008 Oct 24;283(43):29119-25
references: 18703512
references: J Bone Miner Metab. 2005;23(6):411-9
references: 16261446
references: Bone. 2001 May;28(5):491-8
references: 11344048
references: J Cell Physiol. 2013 May;228(5):1060-9
references: 23041979
references: J Biol Chem. 2010 Nov 19;285(47):36410-9
references: 20851880
references: J Bone Miner Res. 2003 Nov;18(11):2060-8
references: 14606520
references: FEBS Lett. 2010 Aug 4;584(15):3242-9
references: 20542036
references: Exp Cell Res. 2003 Nov 15;291(1):201-11
references: 14597420
references: Faraday Discuss. 2004;126:185-95; discussion 245-54
references: 14992406
references: Blood Cells. 1994;20(1):191-9; discussion 200-1
references: 7994060
references: Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):343-55
references: 19897402
references: J Bone Joint Surg Am. 2003;85-A Suppl 3:44-51
references: 12925609
references: Cytokine Growth Factor Rev. 2009 Jun;20(3):213-22
references: 19493693
references: Annu Rev Biochem. 1998;67:753-91
references: 9759503
references: Mol Biol Cell. 2010 Mar 15;21(6):1111-24
references: 20089836
references: J Biol Chem. 2002 May 3;277(18):15514-22
references: 11854297